About the job
For over 25 years, Corcept Therapeutics has dedicated itself to the intricate science of cortisol, a potent hormone that, when dysregulated, is implicated in various diseases.
Our robust commercial portfolio features innovative treatments for hypercortisolism and oncology, and we have pioneered over 1,000 proprietary selective cortisol modulators and glucocorticoid receptor antagonists. With cutting-edge clinical trials targeting hypercortisolism, solid tumors, ALS, and liver disease, Corcept is harnessing the power of cortisol modulation to combat some of the most challenging diseases faced by patients today.
Headquartered in Redwood City, California, we invite you to learn more about our mission at www.corcept.com.
The Oncology Europe MSL position presents a remarkable opportunity to join a well-respected pharmaceutical company on the cusp of launching a potential first-in-class oncology product, complemented by a platform that spans multiple therapeutic areas. The initial oncology MSL team will consist of highly skilled and driven professionals focused on engaging thought leaders, gathering insights, and providing scientific education. Territories will be determined based on the location and expertise of the selected candidates.
The Europe MSL will embody Corcept's commitment to the highest ethical and professional standards, adhering to relevant guidelines, directives, and policies.
Responsibilities:
- Engage in clinically relevant scientific discussions with key opinion leaders in gynecological oncology and related malignancies to deepen understanding of Corcept, the significance of cortisol modulation in oncology, and relacorilant.
- Proactively communicate and educate healthcare professionals on disease states where cortisol modulation may be pertinent. Provide responsive support for inquiries and engage in scientific exchanges regarding Corcept’s clinical trial data and development plan.
- Establish and nurture robust relationships with thought leaders, patient advocacy organizations, and oncology associations (e.g., ESMO, ESGO, and other regional entities) within the oncology field.
- Collect, analyze, and relay insights and intelligence from the medical and scientific community to enhance Corcept's strategic initiatives.

